Genetics and Genomics of Late-Onset Alzheimer's Disease and Its Endophenotypes
نویسندگان
چکیده
1Department of Neurology, G. H. Sergievsky Center, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, New York, NY 10032, USA 2Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada M55 1A8 3Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN 46202, USA 4Department of Medicine, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 5Department of Biomedical Genetics, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 6Department of Neurology, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 7Department of Ophthalmology, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 8Department of Genetics & Genomics, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 9Department of Epidemiology, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA 10Department of Biostatistics, Schools of Medicine and Public Health, Boston University, Boston, MA 02118, USA
منابع مشابه
The role of genetics in alzheimer’s disease
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells die. Alzheimer's disease is the most common cause of dementia and causes a decrease in thinking skills and social behaviors. Alzheimer's disease is more common in people over 65 years old. The risk of developing Alzheimer's disease and other types of dementia increases with age,...
متن کاملMutational Screening in Exon 6 of the PSEN2 Gene in Iranian Patients with Late-Onset Alzheimer\'s Disease
Background and Aims: One of the most important genes involved in Alzheimer's disease (AD) is the presenilin2 (PSEN2) gene, which is one of the main constituents of the gamma-secretase complex. Mutations in this gene promote the formation of amyloid plaques resulting in AD. The study aimed to evaluate the mutation variant in exon 6 of the PSEN2 gene in patients with Late-Onset AD (LOAD). Due to ...
متن کاملMitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
Various studies have suggested that the mitochondrial genome plays a role in late-onset Alzheimer's disease, although results are mixed. We used an endophenotype-based approach to further characterize mitochondrial genetic variation and its relationship to risk markers for Alzheimer's disease. We analyzed longitudinal data from non-demented, mild cognitive impairment, and late-onset Alzheimer's...
متن کاملPsychiatric onset Alexander disease: an important challenge in neuropsychiatric diagnosis
Introduction: Alexander disease is a heterogenous group of diseases with various manifestations based on age of disease onset. This rare leukodystrophy syndrome with mutations in GFAP Gene could present with developmental delay and seizure in infantile form to ataxia and bulbar palsy in adulthood. However psychiatric symptoms are not well-defined and usually evaluate after disease diagnosis not...
متن کاملNeuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene
Neuropsychiatric symptoms, previously denominated as behavioural and psychological symptoms of dementia, are common features of Alzheimer's disease (AD) and are one of the major risk factors for institutionalization. At present, the role of the apolipoprotein E (APOE) gene in the development of neuropsychiatric symptoms in AD patients is unclear. In this paper, we summarized the findings of the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 2011 شماره
صفحات -
تاریخ انتشار 2011